Hearing Loss Trial, Recruiting NCT05923203 Sponsor: Hearts for Hearing Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT05923203
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between the ages of 5 and 17, or adults aged 18 and older, who either have normal hearing or have at least one cochlear implant (a device surgically placed to help with hearing)
  • Participants with a cochlear implant must also have some remaining low-frequency (low-pitched sound) hearing in both ears
  • Participants with a cochlear implant must have a mild to severe hearing loss in the ear without the implant — people with total deafness in one ear only will not be included
  • For cochlear implant users, hearing test results at certain low-pitched sound levels must fall within a specific range in both ears (confirm with trial site)
  • All participants must have thinking and reasoning abilities within the typical range for their age
  • Adult participants must also pass a standard memory and thinking screening test
  • Participants must not have any other conditions that could affect the results, such as autism, a neurological disorder, auditory neuropathy, or general cognitive difficulties
  • Cochlear implant participants must be willing to use their implant together with a hearing aid (a combined approach called EAS technology), and this will be checked using device usage records

Who may not be able to join:

  • Anyone whose non-verbal reasoning score falls below a standard threshold on a cognitive test (confirm with trial site)
  • Adult participants who score below 26 on a standard memory and thinking screening test (the MoCA or HI-MoCA)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: René H Gifford, PhD, Hearts for Hearing

Phone: (405) 548-4300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hearts for Hearing
Registry
ClinicalTrials.gov
Start date
5 December 2022
Est. completion
1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in BEL sentence score demonstrating EAS benefit for speech recognition in noise (CIHA+HA - CI+HA); Change in BKB-SIN score demonstrating EAS benefit for speech recognition in noise (CIHA+HA - CI+HA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov